STOCK TITAN

Vistagen: Commodore Capital reports 3.7% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Vistagen Therapeutics, Inc. (VTGN) is the issuer in an amended Schedule 13G reporting that Commodore Capital LP, Commodore Capital Master LP, and managing partners Michael Kramarz and Robert Egen Atkinson may each be deemed to beneficially own the same 1,690,014 shares as of September 30, 2026. The amount consists of Tranche 2 Warrants to purchase up to 1,690,014 common shares; the reporting persons report shared voting and dispositive power. Their reported ownership is 3.7%, calculated using 44,376,911 shares issued and outstanding as of August 10, 2026, plus the shares issuable under the warrants. The filing identifies ownership of 5% or less of the class.

Beneficial ownership 1,690,014 shares As of September 30, 2026; consists of Tranche 2 Warrants to purchase up to this number of common shares
Ownership percentage 3.7% Calculated using issued and outstanding shares plus shares issuable upon exercise of the Tranche 2 Warrants
Shares issued and outstanding 44,376,911 shares As of August 10, 2026; used in the ownership percentage calculation
Tranche 2 Warrants financial
"consisting of Tranche 2 Warrants to purchase up to 1,690,014 shares"
shared voting power regulatory
"Shared voting power 1,690,014"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power 1,690,014"
beneficially own regulatory
"may be deemed to beneficially own an aggregate of 1,690,014 shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VTGN shares did the reporting persons report?

The four reporting persons each reported that they may be deemed to beneficially own 1,690,014 shares as of September 30, 2026. The amount consists of Tranche 2 Warrants to purchase up to 1,690,014 common shares, and they report shared voting and dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





92840H400

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Commodore Capital LP
Signature:Michael Kramarz
Name/Title:Managing Partner
Date:11/16/2026
Commodore Capital Master LP
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:11/16/2026
Robert Egen Atkinson
Signature:Robert Egen Atkinson
Name/Title:Authorized Signatory
Date:11/16/2026
Michael Kramarz
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:11/16/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement

Keep reading